Publications by authors named "Ahmed Hamed Salem"

54Publications

Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.

Cancer Chemother Pharmacol 2021 Jan 4. Epub 2021 Jan 4.

Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.

View Article and Find Full Text PDF
January 2021

Semimechanistic Modeling to Guide Venetoclax Coadministration with Ritonavir and Digoxin.

Clin Transl Sci 2020 05 13;13(3):555-562. Epub 2020 Mar 13.

Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, Illinois, USA.

View Article and Find Full Text PDF
May 2020

Model-Informed Dosing of Venetoclax in Healthy Subjects: An Exposure-Response Analysis.

Clin Transl Sci 2019 11 7;12(6):625-632. Epub 2019 Aug 7.

AbbVie, North Chicago, Illinois, USA.

View Article and Find Full Text PDF
November 2019

Power determination during drug development: Is optimizing the sample size based on exposure-response analyses underutilized?

CPT Pharmacometrics Syst Pharmacol 2019 Jan 18. Epub 2019 Jan 18.

Abbvie Inc, 1 North Waukegan Road, North Chicago, IL, 60064.

View Article and Find Full Text PDF
January 2019

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.

J Clin Oncol 2018 07 1;36(19):1973-1980. Epub 2018 May 1.

Stephan Stilgenbauer and Johannes Bloehdorn, Ulm University, Ulm; Stephan Stilgenbauer, Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg; Barbara Eichhorst and Michael Hallek, Universitätsklinikum Köln, Köln; Johannes Schetelig, University Hospital, Technische Universität Dresden, Dresden; Clemens-Martin Wendtner, Klinikum Schwabing, Munich; Sebastian Böttcher, University Hospital of Schleswig-Holstein, Kiel, Germany; Peter Hillmen and Talha Munir, St James's University Hospital, Leeds; Anna Schuh, University of Oxford; Anna Schuh, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; John F. Seymour, Peter MacCallum Cancer Centre; John F. Seymour, University of Melbourne; Andrew W. Roberts, Royal Melbourne Hospital, Parkville, Victoria; Stephen P. Mulligan, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Steven Coutre, Stanford University Medical Center, Stanford, CA; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Sarit Assouline, McGill University, Montreal, Quebec, Canada; Matthew S. Davids, Dana-Farber Cancer Institute, Boston, MA; Lang Zhou, Ahmed Hamed Salem, Monali Desai, Brenda Chyla, Jennifer Arzt, Su Young Kim, Maria Verdugo, and Gary Gordon, AbbVie, North Chicago, IL; Ahmed Hamed Salem, Ain Shams University, Cairo, Egypt; and William G. Wierda, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
July 2018